191 related articles for article (PubMed ID: 15800712)
1. Significance of qualitative PCR detection method for preemptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic stem cell transplantation -- single-centre experience.
Skapova D; Racil Z; Dvorakova D; Minarikova D; Mayer J
Neoplasma; 2005; 52(2):137-42. PubMed ID: 15800712
[TBL] [Abstract][Full Text] [Related]
2. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Zhao XS; Yu L; Han W; Zhang XH; Wang Y; Chen Y; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):77-81. PubMed ID: 19563015
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
[TBL] [Abstract][Full Text] [Related]
4. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of cytomegalovirus infection with the polymerase chain reaction and antigenemia in patients after allogenic peripheral stem cell transplantation--comparison of 318 paired samples].
Mayer J; Dvoráková D; Krahulová M; Vorlícek J; Adler J
Cas Lek Cesk; 1999 Jul; 138(14):436-40. PubMed ID: 10566215
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
[TBL] [Abstract][Full Text] [Related]
7. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation.
Mori T; Okamoto S; Watanabe R; Yajima T; Iwao Y; Yamazaki R; Nakazato T; Sato N; Iguchi T; Nagayama H; Takayama N; Hibi T; Ikeda Y
Bone Marrow Transplant; 2002 May; 29(9):777-82. PubMed ID: 12040476
[TBL] [Abstract][Full Text] [Related]
8. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
[TBL] [Abstract][Full Text] [Related]
9. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
[TBL] [Abstract][Full Text] [Related]
10. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
Peggs KS; Preiser W; Kottaridis PD; McKeag N; Brink NS; Tedder RS; Goldstone AH; Linch DC; Mackinnon S
Br J Haematol; 2000 Dec; 111(3):782-90. PubMed ID: 11122138
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative real-time PCR--usefulness in detection and monitoring of CMV infection after hematopeietic stem cells transplant].
Grabarczyk P; Brojer E; Nasiłowska B; Mariańska B
Pol Merkur Lekarski; 2006 Sep; 21(123):227-31. PubMed ID: 17163182
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients.
Cortez KJ; Fischer SH; Fahle GA; Calhoun LB; Childs RW; Barrett AJ; Bennett JE
J Infect Dis; 2003 Oct; 188(7):967-72. PubMed ID: 14513415
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.
Hebart H; Wuchter P; Loeffler J; Gscheidle B; Hamprecht K; Sinzger C; Jahn G; Dietz K; Kanz L; Einsele H
Bone Marrow Transplant; 2001 Jul; 28(2):213-8. PubMed ID: 11509941
[TBL] [Abstract][Full Text] [Related]
17. [Cytomegaloviral infection in patients with hemoblastoses].
Savchenko VG; Troitskaia VV; Misiurin AV; Parovichnikova VN; Isaev VG; Mendeleeva LP; Liubimova LS; Demidova IA; Aksenova EV; Filatov FP
Ter Arkh; 2003; 75(7):52-8. PubMed ID: 12934482
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
[TBL] [Abstract][Full Text] [Related]
19. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
[TBL] [Abstract][Full Text] [Related]
20. Active CMV disease does not always correlate with viral load detection.
Ruell J; Barnes C; Mutton K; Foulkes B; Chang J; Cavet J; Guiver M; Menasce L; Dougal M; Chopra R
Bone Marrow Transplant; 2007 Jul; 40(1):55-61. PubMed ID: 17468776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
